会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 2,5-Dihydro-1,2-thiazino(5,6-b)indole-3-carboxamide-1,1-dioxides and
salts thereof
    • 2,5-二氢-1,2-噻嗪(5,6-b)吲哚-3-甲酰胺-1,1-二氧化物及其盐
    • US4137313A
    • 1979-01-30
    • US872889
    • 1978-01-27
    • Gunter TrummlitzWolfhard EngelErnst SeegerWalter HaarmannGunther Engelhardt
    • Gunter TrummlitzWolfhard EngelErnst SeegerWalter HaarmannGunther Engelhardt
    • A61K31/54A61P7/02A61P29/00C07D209/42C07D513/04C07D513/14A61K31/38
    • C07D513/04C07D209/42C07D513/14Y10S514/822
    • Compounds of the formula ##STR1## WHEREIN R.sub.1 is hydrogen, methyl or ethyl;R.sub.2 is methyl or ethyl;Y is hydrogen, fluorine, chlorine, bromine, methoxy, methyl, ethyl or trifluoromethyl; andAr is 2-thiazolyl which may have one or two methyl or ethyl substituents attached thereto; 5,6-dihydro-4H-cyclopentathiazol-2-yl; 4,5,6,7-tetrahydro-2-benzothiazolyl; 2-benzothiazolyl; 3-isothiazolyl which may have a methyl substituent attached thereto; 2-pyridyl which may have a methyl or hydroxyl substituent attached thereto; 3-pyridyl; 4-pyridyl; 4-pyrimidinyl; pyrazinyl; 2-benzimidazolyl; 2-oxazolyl which may have a methyl substituent attached thereto; 2-benzoxazolyl; or phenyl which may have a fluoro, chloro, bromo, methyl, ethyl, trifluoromethyl or methoxy substituent attached thereto; and non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases. The compounds as well as their salts are useful as antiphlogistics and blood platelet aggregation inhibitors.
    • 式中的化合物,其中R1是氢,甲基或乙基; R2是甲基或乙基; Y是氢,氟,氯,溴,甲氧基,甲基,乙基或三氟甲基; 并且Ar是可以具有一个或两个连接到其上的甲基或乙基取代基的2-噻唑基; 5,6-二氢-4H-环戊基噻唑-2-基; 4,5,6,7-四氢-2-苯并噻唑基; 2-苯并噻唑基 可具有与其连接的甲基取代基的3-异噻唑基; 可以具有连接到其上的甲基或羟基取代基的2-吡啶基; 3-吡啶基; 4-吡啶基; 4-嘧啶基; 吡嗪基 2-苯并咪唑基; 可具有与其连接的甲基取代基的2-恶唑基; 2-苯并恶唑基; 或可具有与其连接的氟,氯,溴,甲基,乙基,三氟甲基或甲氧基取代基的苯基; 和与无机或有机碱形成的无毒的,药学上可接受的盐。 化合物及其盐可用作消炎剂和血小板聚集抑制剂。
    • 3. 发明授权
    • 4-Hydroxy-2H-naphtho[2,1-e]-1,2-thiazine-3-carboxamide-1,1-dioxides and
salts thereof
    • 4-羟基-2H-萘并({2,1-e {9-1,2-噻嗪-3-甲酰胺-1,1-二氧化物及其盐
    • US3992535A
    • 1976-11-16
    • US626623
    • 1975-10-29
    • Gunter TrummlitzHelmut TeufelWolfhard EngelErnst SeegerWalter HaarmannGunther Engelhardt
    • Gunter TrummlitzHelmut TeufelWolfhard EngelErnst SeegerWalter HaarmannGunther Engelhardt
    • C07D275/06C07D279/02C07D417/12C07D513/04A61K31/54
    • C07D275/06C07D279/02
    • Compounds of the formula ##SPC1##WhereinR.sub.1 is hydrogen, methyl or ethyl, andAr is phenyl, 3-chlorophenyl, 3-bromophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3-tolyl, 2-methoxyphenyl, 3-methoxyphenyl, 2-pyridyl, 4-methyl-2-pyridyl, 6-methyl-2-pyridyl, 3-hydroxy-2-pyridyl, 3-pyridyl, 4-pyridyl, 6-chloro-3-pyridazinyl, 2-pyrazinyl, 6-chloro-2-pyrazinyl, 6-chloro-4-pyrimidinyl, 2-thiazolyl, 4-methyl-2-thiazolyl, 4-ethyl-2-thiazolyl, 5-methyl-2-thiazolyl, 5-ethyl-2-thiazolyl, 4,5-dimethyl-2-thiazolyl, 4-ethyl-5-methyl-2-thiazolyl, 5-ethyl-4-methyl-2-thiazolyl, 2-benzothiazolyl, 4,5,6,7-tetrahydro-2-benzothiazolyl, 5,6-dihydro-7H-thiopyrano[4,3-d]thiazol-2-yl, 3-methyl-5-isothiazolyl, 1,3,4-thiadiazolyl, 5-methyl-1,3,4-thiadiazol-2-yl or 5-methyl-3-isoxazolyl,And non-toxic, pharmacologically acceptable salts thereof formed with an inorganic or organic base; the compounds as well as their salts are useful as inhibitors of platelet adhesion and aggregation.
    • 式WHERE R1的化合物是氢,甲基或乙基,Ar是苯基,3-氯苯基,3-溴苯基,2-氟苯基,3-氟苯基,4-氟苯基,3-甲苯基,2-甲氧基苯基,3-甲氧基苯基, 2-吡啶基,4-甲基-2-吡啶基,6-甲基-2-吡啶基,3-羟基-2-吡啶基,3-吡啶基,4-吡啶基,6-氯-3-哒嗪基,2-吡嗪基,6-吡啶基, 4-氯-2-吡嗪基,6-氯-4-嘧啶基,2-噻唑基,4-甲基-2-噻唑基,4-乙基-2-噻唑基,5-甲基-2-噻唑基,5-乙基-2-噻唑基, 4,5-二甲基-2-噻唑基,4-乙基-5-甲基-2-噻唑基,5-乙基-4-甲基-2-噻唑基,2-苯并噻唑基,4,5,6,7-四氢-2- 苯并噻唑基,5,6-二氢-7H-噻喃并[4,3-d]噻唑-2-基,3-甲基-5-异噻唑基,1,3,4-噻二唑基,5-甲基-1,3,4-噻二唑基, 噻二唑-2-基或5-甲基-3-异恶唑基,以及与无机或有机碱形成的非毒性,药理学上可接受的盐; 化合物作为它们的盐作为板材粘合和聚集的抑制剂有用。
    • 10. 发明授权
    • Biphenylyl derivatives
    • 联苯衍生物
    • US3993683A
    • 1976-11-23
    • US577169
    • 1975-05-14
    • Josef NicklErich MullerBerthold NarrWalter HaarmannWolfgang SchroterRudolf Kadatz
    • Josef NicklErich MullerBerthold NarrWalter HaarmannWolfgang SchroterRudolf Kadatz
    • C07C67/00C07C69/76C07C313/00C07C315/04C07C317/10C07C317/18C07C317/24C07C317/44C07C323/16C07C323/45C07C323/52C07C323/60C07C323/65C07D213/30C07D295/185C07C149/40
    • C07D213/30C07C317/10C07C317/18C07C317/24C07C317/44C07C323/16C07C323/45C07C323/52C07C323/60C07C323/65C07D295/185Y10S514/822
    • Compounds of the formula ##SPC1##WhereinR.sub.1 is hydrogen, fluorine, bromine, methyl, methoxy, methylthio, nitro, cyano or, when A is other than methylene, R.sub.2 is hydrogen, R.sub.3 is carboxyl, m is 2 and n is 0, also chlorine;R.sub.2 is hydrogen or fluorine;R.sub.3 is hydrogen, methyl, hydroxymethyl, carboxyl, (alkoxy of 1 to 6 carbon atoms)-carbonyl, methoxy-(alkoxy of 1 to 6 carbon atoms)-carbonyl, (alkenyloxy of 2 to 6 carbon atoms)-carbonyl, (aralkoxy of 7 to 12 carbon atoms)-carbonyl, phenoxy-carbonyl, pyridylmethoxy-carbonyl, amino-carbonyl, (alkyl of 1 to 3 carbon atoms-amino)-carbonyl, (dialkyl of 1 to 3 carbon atoms-amino)-carbonyl, phenylamino-carbonyl, morpholino-carbonyl, piperidino-carbonyl, thiomorpholino-carbonyl, (1-oxidothiomorpholino)-carbonyl or (1,1-dioxido-thiomorpholino)-carbonyl;A is methylene, (alkyl of 1 to 3 carbon atoms)-methylene, di-(alkyl of 1 to 3 carbon atoms)-methylene, hydroxymethyl-methylene, hydroxymethylene or carbonyl;m is 1 or 2; andn is 0, 1, 2 or 3;And, when R.sub.3 is carboxyl, non-toxic salts thereof formed with an inorganic or organic base. The compounds as well as the salts are useful as antithrombotics, anticholesteremics and anticoagulants.
    • 式A的化合物是氢,氟,溴,甲基,甲氧基,甲硫基,硝基,氰基,或当A不是亚甲基时,R 2是氢,R 3是羧基,m是2,n是0,也是氯; R2是氢或氟; R 3是氢,甲基,羟甲基,羧基,(1至6个碳原子的烷氧基) - 羰基,甲氧基 - (1至6个碳原子的烷氧基) - 羰基,(2至6个碳原子的链烯氧基) - 羰基 7至12个碳原子的羰基,苯氧基 - 羰基,吡啶基甲氧羰基,氨基 - 羰基,(1至3个碳原子的烷基 - 氨基) - 羰基,(1至3个碳原子的二烷基 - 氨基) - 羰基, 苯基氨基羰基,吗啉代羰基,哌啶子基 - 羰基,硫代吗啉代羰基,(1-氧硫基吗啉代)羰基或(1,1-二氧化硫代吗啉代)羰基。 A是亚甲基,(1至3个碳原子的烷基) - 亚甲基,二(1至3个碳原子的烷基) - 亚甲基,羟甲基 - 亚甲基,羟基亚甲基或羰基; M IS 1 OR 2; 和N是0,1,2或3; 当R 3为羧基时,其无机盐与无机或有机碱形成。 化合物以及盐可用作抗血栓形成剂,抗胆固醇剂和抗凝剂。